Overview

Variability in Response to Non-steroidal Anti-inflammatory Drugs

Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This research study will evaluate inter-individual variability in the response to the non-steroidal anti-inflammatory drugs (NSAIDs), celecoxib and naproxen, among healthy adults. It will also investigate what factors, like age, sex, or genetic background, cause this variability.
Phase:
Phase 1
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Celecoxib
Naproxen